Engineering cells with electrical stimulation for increased granzyme B accumulation and enhanced cytolytic degranulation may provide a novel perspective for developing anti-tumor treatments, thereby expanding the therapeutic potential alone or in combination with existing adoptive or targeted cell therapies. This evidence concerns the gene GZMB and neoplasm.